Serena El Feghali

PARCC will provide researchers across the university with enhanced hardware, software, and expert support, creating a platform for cutting-edge interdisciplinary research.

The conference, entitled “Healthcare Beyond Borders,” included talks from two keynote speakers, panel sessions, and a career fair, with representatives from Perelman School of Medicine, Boston Consulting Group, and Prenuvo Medical Group.

Researchers at Penn Medicine created an innovative cancer treatment using nano-sized capsules that can target and trigger cancer cell self-destruction.

Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently approved to treat leukemia, lymphoma, and multiple myeloma.

Andrew Modzelewski was named a 2024 Packard Fellow for Science and Engineering for his research in ancient viruses and mobile elements known as retrotransposons.

This agreement will enable faculty, researchers and students to engage in cross-cultural exchanges and advance research in both institutions, according to the Penn Engineering Blog.